BULLISHWHALES
BullishWhales · Analysts · Analyst Profile

Yatin Suneja

Guggenheim · Equity Research Analyst

Analyst rating accuracy & track record

Yatin Suneja does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
ALMSAlumis Inc
Buy$18.00Jun 2025+495.1%Hit
CABACabaletta Bio Inc
Buy$25.00May 2025+61.0%Miss
CABACabaletta Bio Inc
Buy$25.00May 2025+52.1%Miss
PHATPhathom Pharmaceuticals Inc
Buy$12.00May 2025+392.2%Hit
PHATPhathom Pharmaceuticals Inc
BuyApr 2025+122.2%
CABACabaletta Bio Inc
Buy$23.00Apr 2025+111.9%Miss
IFRXInflaRx N.V.
Buy$10.00Mar 2025−27.9%Miss
ZURAZura Bio Limited Class A Ordinary Shares
Buy$15.00Mar 2025+343.4%Miss
LRMRLarimar Therapeutics Inc
Buy$26.00Mar 2025+105.2%Miss
ACETAdicet Bio Inc
Buy$7.00Mar 2025−54.6%Miss
IMVTImmunovant Inc
BuyMar 2025+16.1%
IMVTImmunovant Inc
BuyMar 2025+24.5%
IMVTImmunovant Inc
Buy$44.00Feb 2025+29.7%Miss
SRZNSurrozen Inc
Buy$45.00Jan 2025+20.7%Miss
SYRESpyre Therapeutics Inc.
Buy$65.00Oct 2024−28.7%Miss
ZBIOZenas BioPharma, Inc. Common Stock
Buy$45.00Oct 2024+55.5%Miss
QTTBQ32 Bio Inc
Buy$100.00Jun 2024−84.0%Miss
ABVXAbivax SA American Depositary Shares
Buy$50.00Apr 2024−53.4%Miss
RLMDRelmada Therapeutics Inc
Buy$60.00Sep 2022−92.9%Miss
Go to

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.

v1.0.30